Skip to main content
Equibles

ARGX · Argenx SE · Metrics

Track ARGX — free

Use ARGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$960.04 -21.29 (-2.17%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$60.37B
Shares
62.89M
Volume · Nov 13 226.16K Avg daily vol (3M) 365.92K

ARGX metrics

78 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$960.04
Market cap
$60.37B

Price action

23 metrics
Price change (1W)
+3.5%
Price change (30D)
+13.4%
Price change (3M)
+12.8%
Price change (6M)
+20.1%
Price change (YTD)
+14.2%
Price change (1Y)
+7.7%
Trailing year
Price change (5Y)
+210.1%
52-week high
$1,058.90
52-week low
$663.93
Change from 52-week high
-9.3%
Change from 52-week low
+44.6%
Annualized volatility
37.9%
Annualized volatility (3M)
50.1%
Implied volatility (30D)
40.6%
IV rank (1Y)
60.5
IV percentile (1Y)
75.9
Beta
0.5
RSI (14D)
58.8
Price vs SMA 50
+3.9%
Price vs SMA 200
+11.6%
Avg volume (3M)
365,921
Relative volume
0.6
Average dollar volume
$338.23M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
62.89M

Valuation

12 metrics
P / E (TTM)
35.2
Trailing earnings · reciprocal yield 2.8%
PEG ratio
0.7
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
11.3×
reciprocal yield 8.8%
P / book
7.2
reciprocal yield 13.9%
FCF yield
1.6%
TTM · current market cap
Buyback yield
—
P / FCF
62.2
reciprocal yield 1.6%
P / operating cash flow
62.0
reciprocal yield 1.6%
Earnings yield
2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-22

Profitability

9 metrics
Gross margin
90.2%
Operating margin
30.1%
Trailing 12 months
Net margin
32.2%
Gross profit (TTM)
$4.80B
Operating profit (TTM)
$1.60B
Net income (TTM)
$1.72B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
18.2%
Effective tax rate
1.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$118.34

Growth

11 metrics
Revenue growth YoY
+88.6%
Year over year
Net income growth YoY
+55.1%
Revenue (TTM)
$5.33B
Trailing 12 months
EPS growth YoY
+53.1%
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+112.1%
Revenue CAGR (5Y)
+130.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
20.4%
Return on assets
17.1%
Debt / equity
—
Current ratio
5.1
EBITDA (TTM)
—
Free cash flow (TTM)
$970.03M
Quick ratio
4.9
Interest coverage
392.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.58B
Total assets
$10.03B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$974.19M
Capital expenditures (TTM)
$4.17M
R&D (TTM)
$1.65B
SG&A (TTM)
—
Stock compensation (TTM)
$254.08M
R&D / revenue
31.0%
Stock compensation / revenue
4.8%

Ownership (13F)

9 metrics
13F filers
511
13F filer change QoQ
+29
Institutional ownership
45.5%
Conviction holders (share of 13F filers)
2.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-2.3%
Holder tenure
19.8
Price vs estimated holder cost
+31.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.9%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 461 filings 408 filers Visit website Investor relations